We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.56B
1-Year Est. Return 44.46%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+44.46%
3 Year Est. Return
+161.84%
5 Year Est. Return
+198.84%
10 Year Est. Return
+662.52%
AUM
$1.17B
AUM Growth
-$195M
Cap. Flow
-$131M
Cap. Flow %
-11.23%
Top 10 Hldgs %
42.13%
Holding
252
New
8
Increased
16
Reduced
106
Closed
10

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$17.1M
2
HON icon
Honeywell
HON
+$7.64M
3
GTLS
Chart Industries
GTLS
+$4.6M
4
EQT icon
EQT Corp
EQT
+$2.41M
5
GHM icon
Graham Corp
GHM
+$2.27M

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$21.5M
2
NVDA icon
NVIDIA
NVDA
+$15.4M
3
ADBE icon
Adobe
ADBE
+$9.29M
4
CAT icon
Caterpillar
CAT
+$8.17M
5
GILD icon
Gilead Sciences
GILD
+$7.89M

Sector Composition

Rank Sector Weight
1 Technology 32.79%
2 Industrials 14.22%
3 Healthcare 13.19%
4 Financials 11.99%
5 Communication Services 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VONG icon
251
Vanguard Russell 1000 Growth ETF
VONG
$45.4B
-2,000
Closed -$207K

Similar funds

Philadelphia Trust Company's Q1 2025 Portfolio in Review

As of Q1 2025, Philadelphia Trust Company held 252 positions worth $1.17B, down 14% from $1.36B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Philadelphia Trust Company withdrew a net $131M in Q1 2025, closing 10 positions and reducing 106 holdings. Its most notable exit was Gilead Sciences, an estimated $7.89M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Philadelphia Trust Company opened a new position in Uber worth $17.3M.

  • Philadelphia Trust Company's largest Q1 2025 buy was Uber: 237,212 shares worth $17.3M.
  • Philadelphia Trust Company added most to Honeywell in Q1 2025, an estimated $7.64M increase.
  • Philadelphia Trust Company's biggest Q1 2025 reduction was Vertiv, cutting an estimated $21.5M.
  • Philadelphia Trust Company fully exited Gilead Sciences in Q1 2025, selling an estimated $7.89M.
  • Philadelphia Trust Company's ten largest holdings make up 42% of its $1.17B portfolio in Q1 2025.
  • Philadelphia Trust Company opened 8 new positions and closed 10 in Q1 2025.
  • Philadelphia Trust Company's portfolio value fell 14% quarter-over-quarter to $1.17B.

Based on Philadelphia Trust Company's 13F filing for Q1 2025, filed 13 May 2025.